TargetMol

DP 432

Product Code:
 
TAR-T31568
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20°C
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T31568-100mg100mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31568-500mg500mgEnquire
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
DP 432 is an insulin hexapeptide fragment.
CAS:
57851-61-3
Molecular Weight:
758.87
Purity:
0.98
SMILES:
[C@@H](CC1=CC=CC=C1)(NC([C@H](CC2=CC=CC=C2)NC(CNC([C@H](CCCNC(=N)N)NC(CCN)=O)=O)=O)=O)C(N[C@@H](CC3=CC=C(O)C=C3)C(N)=O)=O

References

Aoyagi H, Iino Y, Takeo T, Horii Y, Morishita Y, Horiuchi R. Effects of OK-432 (picibanil) on the estrogen receptors of MCF-7 cells and potentiation of antiproliferative effects of tamoxifen in combination with OK-432. Oncology. 1997 Sep-Oct;54(5):414-23. PubMed PMID: 9260604. Toyota T, Kitahara A, Goto Y. Effects of hexapeptide, a compound analogous to insulin B chain fragment B-21-26(DP-432) on the glucose uptake into the perfused hind limb of rats. Horm Metab Res. 1978 Jan;10(1):17-20. PubMed PMID: 631735. Menuelle P, Plas C, Taketomi S. Effects of modified insulin B21-B26 fragments on glycogenesis and on insulin-receptor complex fate in cultured fetal hepatocytes. Mol Cell Endocrinol. 1989 Oct;66(2):143-51. PubMed PMID: 2693157. Violi F, Carnevale R, Calvieri C, Nocella C, Falcone M, Farcomeni A, Taliani G, Cangemi R; SIXTUS study group. Nox2 up-regulation is associated with an enhanced risk of atrial fibrillation in patients with pneumonia. Thorax. 2015 Oct;70(10):961-6. doi: 10.1136/thoraxjnl-2015-207178. Epub 2015 Jun 29. PubMed PMID: 26123660.